Uveitis

Uveitis is an inflammatory condition affecting the uveal tract of the eye, which comprises three interconnected structures: the iris, the ciliary body, and the choroid. Together, these structures form the vascular middle layer of the eye and are responsible for regulating light entry, producing aqueous humor, and supplying nutrients to the retina. When any or all of these structures become inflamed, the resulting condition is collectively referred to as uveitis. The disease can be unilateral, affecting only one eye, or bilateral, involving both eyes simultaneously.

The classification of uveitis depends on which part of the uveal tract is primarily affected. Anterior uveitis, the most commonly diagnosed form in dogs, involves inflammation of the iris and ciliary body and is sometimes referred to as iridocyclitis. Posterior uveitis, or choroiditis, affects the choroid at the back of the eye and often involves the overlying retina. When inflammation encompasses the entire uveal tract, the condition is termed panuveitis, which generally carries the most guarded prognosis for vision preservation.

Uveitis is considered one of the most significant ophthalmic emergencies in veterinary medicine because the inflammation disrupts the blood-aqueous barrier, allowing proteins, inflammatory cells, and fibrin to leak into the anterior chamber of the eye. This breakdown of the barrier can set off a cascade of secondary complications including glaucoma, cataracts, retinal detachment, and phthisis bulbi. Without timely and aggressive treatment, uveitis can lead to permanent blindness and chronic pain.

The condition can arise from a wide variety of underlying causes, ranging from systemic infections and immune-mediated diseases to trauma and neoplasia. In many cases, despite thorough diagnostic evaluation, a definitive underlying cause cannot be identified, and the condition is classified as idiopathic. Regardless of the cause, controlling intraocular inflammation rapidly is the immediate priority to minimize structural damage within the eye.

Uveitis in dogs can be triggered by a broad spectrum of infectious, immune-mediated, neoplastic, metabolic, and traumatic causes. Infectious agents are among the most common identifiable triggers and include bacterial organisms such as Leptospira, Brucella, Borrelia burgdorferi, and Ehrlichia canis. Fungal infections, particularly those caused by Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum, are well-recognized causes of severe uveitis, especially in endemic geographic regions. Protozoal parasites including Toxoplasma gondii and Leishmania infantum can also induce intraocular inflammation.

Immune-mediated processes represent another major category of uveitis causes. Lens-induced uveitis occurs when lens proteins leak through an intact or ruptured lens capsule, triggering an immune response within the eye. This is commonly seen in association with cataracts, particularly hypermature cataracts where lens protein leakage is most pronounced. Uveodermatologic syndrome, also known as VKH-like syndrome in dogs, is an autoimmune condition targeting melanocytes that causes bilateral panuveitis along with depigmentation of the skin and hair. Other immune-mediated systemic diseases such as systemic lupus erythematosus can also manifest with uveitis.

Neoplastic causes should always be considered, particularly in older dogs. Intraocular tumors such as melanoma, lymphoma, and metastatic carcinomas can directly invade the uveal tract or cause inflammation through tumor-associated immune responses. Trauma, whether blunt or penetrating, is a straightforward mechanical cause that disrupts the blood-aqueous barrier and initiates an inflammatory cascade. Surgical trauma, particularly following cataract extraction, is another recognized cause of postoperative uveitis.

Certain breeds appear to have a higher predisposition to uveitis or to the conditions that commonly cause it. Golden Retrievers are overrepresented in cases of pigmentary uveitis, a breed-specific condition involving the formation of uveal cysts and progressive pigment dispersion. Samoyeds, Siberian Huskies, and Akitas are predisposed to uveodermatologic syndrome. Cocker Spaniels are at increased risk for lens-induced uveitis due to their high prevalence of hereditary cataracts. Dogs living in or traveling through regions endemic for systemic fungal infections face elevated risk for fungal uveitis.

The clinical signs of uveitis can range from subtle to dramatic depending on the severity of inflammation, the portion of the uveal tract involved, and the duration of the disease before presentation. One of the earliest and most consistent signs is ocular pain, which dogs may express through blepharospasm (squinting), excessive tearing (epiphora), photophobia (aversion to light), and reluctance to have the head or face touched. Some dogs may paw at the affected eye or rub their face against furniture or the ground.

On physical examination, the affected eye often appears reddened due to conjunctival hyperemia and episcleral injection. The cornea may show edema, presenting as a bluish-white haze across the surface. A hallmark finding of anterior uveitis is aqueous flare, which refers to the Tyndall effect caused by protein leakage into the anterior chamber, making the normally clear aqueous humor appear cloudy or hazy when illuminated with a focal light source. In more severe cases, inflammatory cells may settle in the ventral anterior chamber, forming a visible hypopyon, or blood may accumulate as a hyphema.

Miosis, or constriction of the pupil, is another classic sign of anterior uveitis and occurs due to spasm of the iris sphincter muscle caused by inflammatory mediators. This contrasts with the mydriasis typically seen in acute glaucoma, making pupil size an important differentiating clinical sign. The iris itself may appear swollen, discolored, or dull compared to the normal eye, and in chronic cases, the iris may develop posterior synechiae, which are adhesions between the iris and the anterior lens capsule that can permanently distort pupil shape.

Intraocular pressure in eyes with uveitis is typically low (hypotony) because inflammation of the ciliary body reduces aqueous humor production. However, if inflammatory debris or synechiae obstruct aqueous outflow, secondary glaucoma can develop, causing paradoxically elevated intraocular pressure. Dogs with posterior uveitis or panuveitis may additionally show signs of vision impairment, including bumping into objects, hesitancy in unfamiliar environments, or difficulty navigating in low light. Fundoscopic examination in cases of posterior uveitis may reveal chorioretinal lesions, retinal edema, retinal detachment, or vitreal opacities.

Diagnosing uveitis requires a thorough ophthalmic examination combined with systemic diagnostic testing to identify underlying causes. The ophthalmic evaluation typically begins with assessment of the menace response, dazzle reflex, and pupillary light reflexes to gauge visual function and neurologic integrity of the visual pathways. Careful external examination under magnification allows the veterinarian to evaluate the eyelids, conjunctiva, cornea, anterior chamber, and iris for signs of inflammation.

Slit-lamp biomicroscopy is an essential tool for evaluating the anterior segment in detail. It enables the clinician to detect aqueous flare, identify keratic precipitates on the corneal endothelium, visualize fibrin strands or membranes within the anterior chamber, and assess the iris surface for abnormalities such as rubeosis iridis (neovascularization) or nodular infiltrates. Tonometry to measure intraocular pressure is performed to confirm the expected hypotony and to rule out secondary glaucoma, which requires a fundamentally different treatment approach.

Indirect ophthalmoscopy is used to examine the posterior segment, including the vitreous, retina, optic nerve, and choroid. In cases of posterior uveitis, this examination may reveal focal or multifocal chorioretinal lesions, subretinal fluid accumulation, retinal hemorrhages, or retinal detachment. Ocular ultrasound (B-scan ultrasonography) becomes invaluable when opacities in the anterior segment or vitreous prevent direct visualization of the posterior segment, and it can identify vitreal debris, retinal detachment, intraocular masses, and lens subluxation.

Systemic diagnostic workup is critical because uveitis frequently reflects an underlying systemic disease. A minimum database including complete blood count, serum chemistry panel, and urinalysis provides baseline information and may reveal abnormalities suggestive of infection, organ dysfunction, or neoplasia. Infectious disease testing should be tailored to geographic location and exposure risk but commonly includes serology or PCR testing for tick-borne diseases, leptospirosis, fungal infections, and toxoplasmosis. Thoracic radiographs and abdominal ultrasound help evaluate for systemic fungal disease, neoplasia, or organ involvement. In cases where intraocular neoplasia is suspected, advanced imaging such as CT or MRI of the orbits may be warranted. Aqueous humor paracentesis, the collection of a small sample of fluid from the anterior chamber, can be performed for cytology, culture, and PCR testing when the diagnosis remains elusive.

Treatment of uveitis aims to control intraocular inflammation, relieve pain, prevent secondary complications, and address the underlying cause when identified. Topical corticosteroids, most commonly prednisolone acetate 1% ophthalmic suspension, are the cornerstone of anti-inflammatory therapy for anterior uveitis. These drops are typically administered frequently in the initial phase, sometimes as often as every one to two hours, and then gradually tapered as inflammation resolves. Topical nonsteroidal anti-inflammatory drugs such as flurbiprofen, diclofenac, or ketorolac may be used as an adjunct or as an alternative when corticosteroids are contraindicated, such as in cases of corneal ulceration.

Topical atropine 1% is an essential component of uveitis management. This cycloplegic and mydriatic agent serves three important functions: it relieves the painful ciliary spasm that accompanies anterior uveitis, dilates the pupil to prevent the formation of posterior synechiae, and stabilizes the blood-aqueous barrier to reduce further protein leakage. Atropine should be used cautiously in dogs predisposed to glaucoma and requires monitoring of intraocular pressure because it can impair aqueous outflow.

Systemic anti-inflammatory therapy is frequently necessary, particularly in cases of bilateral uveitis, posterior uveitis, panuveitis, or uveitis associated with systemic disease. Oral prednisone or prednisolone at immunosuppressive doses is commonly prescribed, with gradual tapering over weeks to months as the clinical response permits. In cases of immune-mediated uveitis that are refractory to corticosteroids or require long-term therapy, steroid-sparing immunosuppressive agents such as azathioprine, mycophenolate mofetil, or cyclosporine may be employed.

When an infectious cause is identified, appropriate antimicrobial therapy is paramount. Systemic antifungal agents such as fluconazole or itraconazole are required for fungal uveitis, often administered for extended periods of several months. Antibiotic therapy is directed at the specific bacterial organism involved, with doxycycline being a common choice for tick-borne diseases. It is critically important to note that immunosuppressive therapy must be used cautiously or avoided altogether when an active infection is present, as suppressing the immune response can worsen the infection. In some cases, anti-inflammatory therapy must be carefully balanced with antimicrobial treatment under close veterinary supervision.

Uveitis is a condition with significant potential for secondary complications, many of which can cause permanent vision loss even after the primary inflammation has been controlled. Secondary glaucoma is one of the most feared complications and can develop through several mechanisms. Inflammatory debris, fibrin, and cells can physically obstruct the trabecular meshwork and drainage angle, preventing normal aqueous humor outflow. Posterior synechiae can lead to iris bombe, where aqueous humor trapped behind the iris causes it to bow forward and obstruct the drainage angle. Peripheral anterior synechiae, where the iris adheres to the peripheral cornea, can permanently close the drainage angle.

Cataract formation is another common sequela of uveitis. The inflammatory environment within the eye disrupts the normal metabolism of the lens, leading to progressive opacification. Lens-induced uveitis can create a self-perpetuating cycle where cataracts cause uveitis, which in turn accelerates cataract progression, further increasing lens protein leakage and inflammation. This cycle is particularly problematic in breeds already predisposed to cataract formation.

Retinal detachment can occur in cases of posterior uveitis or panuveitis when subretinal fluid accumulation or traction from inflammatory membranes physically separates the neurosensory retina from the underlying retinal pigment epithelium. This complication carries a poor prognosis for visual recovery, particularly if it is extensive or longstanding. Vitreal degeneration with liquefaction, opacification, or organization of inflammatory debris within the vitreous cavity can also impair vision.

Phthisis bulbi represents the end stage of severe or chronic uveitis and refers to the shrinkage and atrophy of the globe. This occurs when prolonged ciliary body inflammation severely reduces aqueous humor production, leading to chronic hypotony and eventual collapse of the globe. A phthisical eye is permanently blind and is often cosmetically disfigured. In some cases, enucleation (surgical removal of the eye) may be recommended for comfort if the phthisical eye is painful, or if an intraocular tumor is suspected as the underlying cause of the uveitis.

Golden Retriever pigmentary uveitis, also referred to as Golden Retriever uveitis or pigmentary and cystic glaucoma, is a breed-specific condition that warrants special discussion due to its prevalence and unique clinical features. This condition is characterized by the development of uveal cysts arising from the posterior iris epithelium and the inner ciliary body epithelium, along with progressive pigment dispersion within the anterior and posterior chambers of the eye.

The pathogenesis of this condition involves the formation of thin-walled, pigmented cysts that arise from the posterior surface of the iris and the ciliary body. These cysts can become numerous, coalescing to form large clusters that occupy significant space within the anterior and posterior chambers. As the cysts enlarge and proliferate, they release pigment granules into the aqueous humor. This dispersed pigment accumulates within the trabecular meshwork and drainage pathways of the eye, progressively obstructing aqueous outflow and leading to secondary glaucoma.

Clinically, affected dogs initially present with visible uveal cysts that can be observed through the pupil or within the anterior chamber. As the disease progresses, pigment deposition becomes evident on the anterior lens capsule, the corneal endothelium, and within the drainage angle. Aqueous flare and low-grade anterior uveitis develop, and intraocular pressure may fluctuate before eventually becoming consistently elevated. The condition is bilateral in the vast majority of cases, though one eye may be more severely affected than the other.

The condition is believed to have a hereditary component, though the precise mode of inheritance has not been fully characterized. Research suggests that a significant proportion of Golden Retrievers over the age of five years have some degree of uveal cyst formation, although not all progress to clinically significant disease. Management focuses on controlling inflammation with topical anti-inflammatory agents, monitoring intraocular pressure closely, and instituting antiglaucoma therapy when pressure elevation is detected. Despite treatment, many affected dogs eventually develop refractory glaucoma that may necessitate enucleation or placement of an intrascleral prosthesis.

The prognosis for dogs with uveitis varies widely depending on the underlying cause, the severity and duration of inflammation before treatment initiation, the presence of secondary complications, and the response to therapy. Cases of traumatic uveitis with no other complicating factors generally carry a favorable prognosis when treated promptly and aggressively, with many dogs achieving full resolution of inflammation and preservation of vision.

Infectious causes of uveitis have a variable prognosis that depends largely on the specific pathogen involved and the extent of ocular and systemic disease. Tick-borne diseases such as ehrlichiosis and Lyme disease often respond well to appropriate antibiotic therapy, with concurrent resolution of the uveitis. Fungal uveitis, particularly that caused by systemic mycoses, tends to carry a more guarded prognosis due to the chronic nature of these infections, the need for prolonged antifungal therapy, and the potential for recurrence.

Immune-mediated uveitis, including uveodermatologic syndrome and lens-induced uveitis, often requires lifelong management with immunosuppressive therapy. While inflammation can frequently be controlled with appropriate medication, the chronic nature of these conditions means that secondary complications such as cataracts, glaucoma, and synechiae may develop over time despite ongoing treatment. Regular monitoring by a veterinary ophthalmologist is essential for early detection and management of these complications.

Idiopathic uveitis, where no underlying cause can be identified, presents a unique prognostic challenge because the unpredictable nature of the disease makes it difficult to anticipate the clinical course. Some dogs with idiopathic uveitis experience a single episode that resolves with treatment, while others develop recurrent or chronic inflammation requiring long-term medication. Owners should be counseled that uveitis management often involves a long-term commitment to frequent veterinary visits, diligent medication administration, and ongoing monitoring of intraocular pressure and visual function.

Managing a dog with uveitis at home requires dedication, consistency, and close collaboration with the veterinary care team. Medication administration is a central aspect of home management, and owners must be comfortable with applying topical ophthalmic drops and ointments, which may need to be given multiple times daily during acute flare-ups. Proper technique for administering eye drops is important to ensure the medication reaches the ocular surface effectively and to avoid contaminating the dropper tip, which could introduce bacteria into the medication bottle.

Owners should learn to recognize the early signs of uveitis flare-ups so that treatment intensification can begin promptly. Increased squinting, tearing, redness, cloudiness of the eye, or any change in the appearance of the pupil or iris should prompt immediate veterinary evaluation. Early intervention during recurrences can help prevent the cumulative damage that occurs with each episode of uncontrolled inflammation. Keeping a log of symptoms, medications, and veterinary visits can be helpful for tracking disease progression and treatment response over time.

Environmental modifications may be necessary for dogs with impaired vision as a result of uveitis or its complications. Maintaining consistent furniture placement, using baby gates to block access to stairs or hazardous areas, and providing tactile or auditory cues near obstacles can help visually impaired dogs navigate their environment safely. Dogs that have lost vision in one or both eyes can adapt remarkably well, particularly in familiar surroundings, and most continue to enjoy a good quality of life with appropriate support and accommodations.

Regular follow-up appointments with a veterinary ophthalmologist are a non-negotiable component of managing uveitis. These visits typically include intraocular pressure measurement, slit-lamp examination, and indirect ophthalmoscopy to assess the status of inflammation and screen for developing complications. The frequency of these visits depends on the severity and stability of the disease but may range from weekly during acute episodes to every three to six months during stable periods. Pet insurance or financial planning for ongoing ophthalmic care is worth considering, as the cumulative costs of long-term management, specialist visits, and potential surgical interventions can be substantial.

True prevention of uveitis is not always possible because many of the underlying causes, such as immune-mediated disease or idiopathic processes, cannot be predicted or avoided. However, several strategies can reduce the risk of certain preventable causes and improve outcomes through early detection. Vaccination against Leptospira species, where geographically appropriate and based on risk assessment, can help prevent leptospirosis-associated uveitis. Tick prevention through the consistent use of veterinary-recommended tick control products reduces the risk of tick-borne infections that can trigger uveitis.

For breeds known to be predisposed to conditions that cause uveitis, such as Golden Retrievers at risk for pigmentary uveitis or breeds prone to hereditary cataracts with secondary lens-induced uveitis, proactive ophthalmic screening is highly recommended. Annual or biannual examinations by a veterinary ophthalmologist can detect early signs of uveal cyst formation, incipient cataracts, or subclinical inflammation before significant damage has occurred. The Canine Eye Registration Foundation (CERF) examinations, now administered through the Orthopedic Foundation for Animals (OFA), provide standardized eye screenings that are particularly valuable for breeding dogs.

Responsible breeding practices play a role in reducing the prevalence of hereditary conditions associated with uveitis. Breeding dogs should undergo thorough ophthalmic evaluation, and dogs with diagnosed hereditary ocular conditions should be removed from breeding programs. Genetic testing, where available, can help identify carriers of conditions associated with uveitis risk and guide informed breeding decisions.

General eye health awareness is beneficial for all dog owners regardless of breed. Regularly inspecting the eyes for redness, discharge, cloudiness, or changes in pupil size takes only a moment but can lead to early detection of ocular disease. Avoiding ocular trauma by using protective eyewear during activities with exposure to debris, such as riding in vehicles with heads out windows or running through dense brush, is a practical preventive measure. Prompt veterinary attention for any eye injury, no matter how minor it may appear, is important because even small corneal scratches or blunt trauma can trigger uveitis if the blood-aqueous barrier is compromised.